文献速递基础与转化研究新药、器械与细胞基因治疗研发

RNF41调控巨噬细胞驱动的纤维化消退与肝再生

RNF41 orchestrates macrophage-driven fibrosis resolution and hepatic regeneration.
PubMed 文献 · Sci Transl Med · 2023-07-12

研究揭示RNF41在趋化至小鼠纤维化肝脏及患者肝硬化肝脏的CD11b+巨噬细胞中表达下调,且与肝硬化病因无关。通过树状聚合物-石墨纳米颗粒(DGNP)将质粒导入CD11b+巨噬细胞恢复RNF41表达,可改善纤维化小鼠肝纤维化、减轻肝损伤并刺激肝再生,该效应主要由胰岛素样生长因子1介导;而敲低巨噬细胞RNF41则加重炎症、纤维化、肝损伤并降低生存率。

要点

  • RNF41在纤维化肝脏及肝硬化患者CD11b+巨噬细胞中表达下调,与病因无关。
  • DGNP介导的巨噬细胞RNF41恢复可改善小鼠肝纤维化、减轻肝损伤并促进肝再生。
  • 巨噬细胞RNF41敲低加重炎症、纤维化、肝损伤并降低生存率。

核心结论

  • 巨噬细胞RNF41参与调控肝脏炎症、纤维化和再生,为慢性肝病及其他炎症纤维化疾病提供治疗策略依据。

研究设计与样本

  • 研究在小鼠纤维化肝脏和患者肝硬化肝脏中检测RNF41表达,并设计巨噬细胞选择性DGNP基因治疗以恢复或敲低巨噬细胞RNF41。

主要发现

  • RNF41在趋化至小鼠纤维化肝脏及患者肝硬化肝脏的CD11b+巨噬细胞中表达下调,与肝硬化病因无关。
  • TNF-α持续炎症进行性降低巨噬细胞RNF41表达。
  • DGNP偶联质粒诱导CD11b+巨噬细胞RNF41表达,改善肝纤维化、减少肝损伤并刺激肝再生,伴或不伴肝切除的纤维化小鼠均如此。
  • 该治疗效应主要由诱导胰岛素样生长因子1介导。
  • 敲低巨噬细胞RNF41加重炎症、纤维化、肝损伤并降低生存率。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hepatic inflammation is a common trigger of chronic liver disease. Macrophage activation is a predictive parameter for survival in patients with cirrhosis. Ring finger protein 41 (RNF41) negatively regulates proinflammatory cytokines and receptors; however, the precise involvement of macrophage RNF41 in liver cirrhosis remains unknown. Here, we sought to understand how RNF41 dictates macrophage fate in hepatic fibrosis and repair within the inflammatory milieu. We found that RNF41 expression is down-regulated in CD11b+ macrophages recruited to mouse fibrotic liver and to patient cirrhotic liver regardless of cirrhosis etiology. Prolonged inflammation with TNF-α progressively reduced macrophage RNF41 expression. We designed a macrophage-selective gene therapy with dendrimer-graphite nanoparticles (DGNPs) to explore the influence of macrophage RNF41 restoration and depletion in liver fibrosis and regeneration. RNF41 expression induced in CD11b+ macrophages by DGNP-conjugated plasmids ameliorated liver fibrosis, reduced liver injury, and stimulated hepatic regeneration in fibrotic mice with or without hepatectomy. This therapeutic effect was mainly mediated by the induction of insulin-like growth factor 1. Conversely, depletion of macrophage RNF41 worsened inflammation, fibrosis, hepatic damage, and survival. Our data reveal implications of macrophage RNF41 in the control of hepatic inflammation, fibrosis, and regeneration and provide a rationale for therapeutic strategies in chronic liver disease and potentially other diseases characterized by inflammation and fibrosis.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Moreno-Lanceta A, Medrano-Bosch M, Fundora Y, et al. RNF41 orchestrates macrophage-driven fibrosis resolution and hepatic regeneration. Sci Transl Med. 2023. PMID: 37437019. doi:10.1126/scitranslmed.abq6225

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。